Alpha Cognition Inc.
For the period ended Mar 25, 2026. Filed Mar 26, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Mar 25, 2026 · Filed Mar 26, 2026
Use the contents to explore the available documents and sections.
ACOG$8.29+1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · INDICATION AND USAGE
INDICATION AND USAGE
ZUNVEYL is a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.